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Accepted 6 June 2016The U.S. medical environment continues to evolve with issues from Privacy to EMR, Insurance regulations,
Physician Access and Healthcare Reform, and MACRA (Medicare Access and CHIP Reauthorization Act) on
the discussion table. Not since the advent of Medicare and Medicaid in the mid 1960’s, have we seen such
widespread changes in themedical healthcare environment (Centers for Medicare andMedicaid Services).
Physicians, industry, patients and consumers are affected by the changes. These four groups have historical-
ly worked as separate entities, but are now key stakeholders in the future of dermatology. As stakeholders
collaborating in building a future together, the dermatologists/physicians will help to ensure and preserve
the quality of patient care and best patient outcomes. In the Executive Forum, leaders from the Women’s
Dermatologic Society and Industry, explored ﬁve important areas: 1) A ﬁve-year outlook of Dermatology
and Medicine; 2) Access of Industry to Dermatologists and Trainees; 3) The New Practice Environment;
4) Doing Things Differently; and 5) Unmet Specialty Needs. The collaborative group explored solutions
for our specialty and the patients we serve.
©2016TheAuthors. Published byElsevier Inc. onbehalf ofWomen's Dermatologic Society. This is anopenaccess
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
In keeping with its mission of “Physicians, Leaders and Mentors,”
the Women’s Dermatologic Society brought together key physicians
and industry leaders to identify the challenges, brainstorm solutions,
and envision the future of the dermatology specialty.
The Women’s Dermatologic Society is the third largest
Dermatologic Society in the U.S., and is composed of members from
32 countries. Membership is 90% female, 10%male, and encompasses
the diversity of Dermatology with academic, private practice,
practice, and industry membership.
Forum Discussion Topics
The ﬁve-year outlook: Insurance reimbursement and formulary
covered prescriptions continue to decline. Ofﬁce-based dermatologicbehalf ofWomen'sDermatologic Sodisorders are not viewed as life-threatening or often as important as
other medical issues, which further threatens adequate reimburse-
ment. In contrast, hospital-based inpatient dermatology services,
such as leg ulcer care, are highly utilized and adequately
reimbursed (Turhune, 2012). As a result, a two-tier system of self-
pay and insurance reimbursement has developed. For example,
acne, themost common skin disorder in the U.S., is not covered by in-
surance in many states (Drummond, 2013). Given their uncertainty
about insurance reimbursement, patients are often forced to pay for
treatment as an out‐of-pocket expense. Similar to Dentistry, success
will be mandated by balancing the cash pay vs. insurance-
reimbursed segments within the medical practice. Nationally, the
demand for dermatological services is increasing and the specialty
is experiencing workforce challenges, with physician extenders
increasingly becoming the primary providers for dermatology
services (American Medical Association).ciety. This is an open access article under theCCBY-NC-ND license (http://creativecommons.
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lines have limited the access of pharmaceutical representatives to
physicians, including residents and fellows, outside of CMEmeetings.
The provision of prescription samples to patients is restricted and
industry-sponsored events at training institutions are prohibited.
The Sunshine Act, which mandates reporting of all ﬁnancial interac-
tionwith the pharma industry, has further decreased dermatologists’
interactionwith the industry representatives, both in educational and
advisory capacities. Mentoring, networking and grassroots initiatives,
such as those sponsored by WDS Regional networking groups,
can bridge the learning gaps for trainees and young physicians,
while ensuring appropriate trainee-industry relations.
Doing Things Differently: A consensus meeting with our indus-
try partners provided important perspective and input into strategic
planning for Dermatology. To facilitate that input, three needs were
identiﬁed. 1) Provide continuing education for dermatologists about
the requirements and ramiﬁcations of the Sunshine Act. 2) Educate
the public about the value of physician-industry collaboration and
dialogue. 3) Prevent “swapouts” of generic medication for a brand-
name medication. Concern was expressed about the frequency of
pharmacy “swapouts” when a brand-name medication is desired
based on unique properties but a generic “equivalent” is substituted
without the knowledge or understanding of the patient or
notiﬁcation of the prescribing dermatologist. Prevention of these
“swapouts” is an opportunity for physicians, industry
representatives, and patients to develop educational materials
clarifying the importance of physician prescription compliance by
pharmacy and insurance companies. Furthermore, The American Col-
lege of Clinical Pharmacy issued the following guideline for pharma-
cists to abide by: Pharmacists should not solicit or accept gifts from
industry thatmight inﬂuence or appear to inﬂuence objectivity, inde-
pendence, or fairness in clinical and professional judgment).
New Practice Environment: Increased and optimal utilization of
social media and technology will be critical in communicating with
patients and colleagues in this newpractice environment. A key orga-
nizationalmessage of theWomen’s Dermatologic Society is providing
service to women and families worldwide. This message, as well as
the goal to address career challenges, is gender-neutral and should
engage both male and female dermatologists and trainees.
Partnering with industry colleagues in providing unique
educational opportunities for our membership is in the best interest
of all stakeholders.
Unmet needs: A recent WDS member survey focused on unmet
needs for the Dermatologist. The top two needs were 1) survivaland growth of the dermatologist in the newhealth care environment,
2) positioning the dermatologist as the skin care specialist
and experts in skin, hair, nail and mucous membrane disorders. The
proposed solutions included: 1) an expansion of WDS networking
events to include subjects such as government regulations and 2) Ex-
ploring and utilizing available social media for a public and physician
communications campaign to emphasize the importance of the
specialized training and abilities of Dermatologists.
Summary
The Key Factor for success is the recognition of the beneﬁts of
collaborative efforts between the dermatologist/physician, industry
(pharma) and the public. The changing practice environment is chal-
lenging, but offers us an opportunity to be proactive and innovative.
Let us unite and take up this challenge.
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